Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
04/2014
04/09/2014CN101768109B Bi-methyl fluoride sulfones compound and application thereof
04/09/2014CN101528704B Serine-threonine protein kinase and PARP modulators
04/08/2014US8691998 Catalysts containing N-heterocyclic carbenes for enantioselective synthesis
04/08/2014US8691986 Azetidine and piperidine compounds useful as PDE10 inhibitors
04/08/2014US8691984 Method of storing triallyl isocyanurate
04/08/2014US8691833 Heterocyclic aspartyl protease inhibitors
04/08/2014US8691817 Sulfonic amide and sulfoximine-substituted diaryl-dihydropyrimidinones and usage thereof
04/08/2014US8691573 Stem cell cultures
04/08/2014CA2563607C 4,5-disubstituted-2-aryl pyrimidines
04/08/2014CA2538315C Matrix metalloproteinase inhibitors
04/03/2014WO2014051056A1 Crystals of glycine derivative and pharmaceutical use thereof
04/03/2014WO2014050874A1 Novel crystalline form of rosuvastatin calcium and production method therefor
04/03/2014WO2014049578A1 New anti-invasive compounds
04/03/2014WO2014048532A1 Quinazolinone derivatives as parp inhibitors
04/03/2014WO2014048065A1 Triazolyl derivatives as syk inhibitors
04/03/2014WO2014047996A1 New crystalline form of rosuvastatin methyl ester and preparation method thereof
04/03/2014WO2014047707A1 Heteroaromatic compounds, method for preparing the compounds, pharmaceutical compositions, uses and method for treating acute and chronic pain
04/03/2014US20140094604 New intermediates and processes for preparing ticagrelor
04/03/2014US20140094465 Compounds as S-Nitrosoglutathione Reductase Inhibitors
04/02/2014EP2712865A1 Improved process for the preparation of ambrisentan
04/02/2014EP2712864A1 Preparation of azoxystrobin
04/02/2014EP2712862A1 New anti-invasive compounds
04/02/2014EP2712861A1 Thioacetate compounds, compositions and methods of use
04/02/2014CN103694180A Pyrimidine-5-formate compound as well as preparation method and application thereof
04/02/2014CN103690972A 18F-labeled quinazoline type EGFR (epidermal growth factor receptor) positron tracer, as well as preparation method and application thereof
04/02/2014CN102659691B Method for preparing 4,6-dichloro-5-amino-2-(propylsulfanyl)pyrimidine
04/02/2014CN102617487B Multi-substituted pyrimidinones compounds as well as preparation method and application thereof
04/02/2014CN102492011B Method for preparing antibacterial compound from scorpion
04/02/2014CN102348687B Sodium salt of 5-cyclopropyl-2-{[2-(2,6- difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as DHODH inhibitor
04/02/2014CN102153517B Diaryl pyrimidone hydrazone derivatives and preparation method and application of diaryl pyrimidone hydrazone derivatives
04/02/2014CN102143750B Macrocyclics pyrimidines as aurora kinase inhibitors
04/02/2014CN102046608B 3,4-dihydropyrimidine TRPA1 antagonists
04/02/2014CN101346357B Aminodihydrothiazine derivative
04/01/2014US8686154 Compounds and compositions for delivering active agents
04/01/2014US8686142 2-aminopyrimidine modulators of the histamine H4 receptor
04/01/2014US8686141 Process for preparing N-substituted hydroxypyrimidinone carboxamides
04/01/2014US8686002 Heterocyclic compounds and their use as binding partners for 5-HT5 receptors
04/01/2014US8685991 Anti-infective agents and uses thereof
04/01/2014US8685989 Nitrogen-containing six-membered aromatic ring derivatives and pharmaceutical products containing the same
04/01/2014US8685985 Selective insecticides based on anthranilic acid diamides and safeners
04/01/2014US8685978 Spectinamides as anti-tuberculosis agents
04/01/2014US8685973 Pyrimidine cyclohexyl glucocorticoid receptor modulators
04/01/2014US8685964 Heterocyclic compounds as pesticides
04/01/2014CA2654318C Sulphimides as protein kinase inhibitors
04/01/2014CA2619919C Diaminopyrimidines as p2x3 and p2x2/3 modulators
04/01/2014CA2604967C Pyrimidine derivatives and their use as p2y12 receptor antagonists
03/2014
03/27/2014WO2014047232A2 C-rel inhibitors and uses thereof
03/27/2014WO2014045029A1 2-(2-aminocyclohexyl)amino-pyrimidine-5-carboxamides as spleen tyrosine kinasei(syk) inhibitors
03/27/2014US20140088126 Rosuvastatin Enantiomer Compounds
03/27/2014US20140088125 Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease
03/27/2014US20140088100 Inhibitors of the fibroblast growth factor receptor
03/27/2014US20140088095 Method for treating pain, anxiety or depression using carbamoyloxy alkanoyl piperazine compound
03/27/2014US20140087311 Developable bottom anti-reflective coating
03/26/2014EP2709990A1 1-(arylmethyl)quinazoline-2,4(1h,3h)-diones as parp inhibitors and the use thereof
03/26/2014EP2709989A1 Quinazoline derivatives for the treatment of viral infections and further diseases
03/26/2014EP2709988A1 Process for preparing [4,6-bis-dimethylamino-2-[4-(4-trifluoromethylbenzoyl-amino)benzyl]pyrimidin-5-yl]acetic acid
03/26/2014EP2709985A1 Amine derivatives as potassium channel blockers
03/26/2014CN103664963A Method for synthesizing quinazolino indazole derivatives
03/26/2014CN103664906A 6, 6-dimethyl-6H- benzo [cd] pyrene derivative and application thereof
03/26/2014CN103664884A Tyrosine kinase inhibitor for nitrogen hetero-aromatic ring and derivatives thereof
03/26/2014CN103664875A Novel method for synthesizing 1,4,5,6-tetrahydropyrimidine derivative
03/26/2014CN103664802A Quinazoline analogs as receptor tyrosine kinase inhibitors
03/26/2014CN103664801A Method of preparing Alogliptin
03/26/2014CN103664800A Compounds for treating narrow chamber angle and application thereof
03/26/2014CN103664799A Compounds for treating narrow chamber angle and application thereof
03/26/2014CN103664798A Compounds for treating traumatic brain injury diseases and application thereof
03/26/2014CN103664797A Compounds for treating narrow chamber angle and application thereof
03/26/2014CN103664796A Synthesis method of 5-[2-(5-carboxyl-pyrimidyl)]-1,3-benzene dicarboxylic acid
03/26/2014CN103664787A Alkyne heteraromatic ring compound and application thereof
03/26/2014CN103657340A Highly-selective hydrogen sulfide gas capturing and absorbing medium
03/26/2014CN103656694A 18F-labelled quinazolines irreversible EGFR (epidermal growth factor receptor) positive electron tracer agent, as well as preparation method and application thereof
03/26/2014CN103656693A 18F labeled quinazoline class EGFR (Epidermal Growth Factor Receptor) positron tracer agent and preparation method and application thereof
03/26/2014CN102887836B L-phenylglycine derivative and application thereof
03/26/2014CN102625797B Substituted heterocyclic compounds as kinases inhibitors and method of use thereof
03/26/2014CN102532039B Application of 5-fluoropyrimidine-4(3H)-ketone compound in preparation of anti-tumor medicaments
03/26/2014CN102391191B Piperazine di-thiocarboxylic acid ester derivative of 2,4-di-aminoquinazoline, as well as preparation method and anti-tumor application of the derivative
03/26/2014CN102304094B Preparation method of sulfadoxine and intermediate thereof
03/26/2014CN102056905B Novel uracil compound having inhibitory activity on human deoxyuridine triphosphatase or salt thereof
03/26/2014CN101918372B Process for preparing N-substituted hydroxypyrimidinone carboxamides
03/26/2014CN101715442B Heterocyclic aspartyl protease inhibitors
03/25/2014US8680110 P2X4 receptor antagonist
03/25/2014US8680107 Activators and therapeutic applications thereof
03/25/2014US8680079 Tetrahydro-imidazo [1,5-A] pyridyin derivatives as aldosterone synthase inhibitors
03/25/2014CA2699989C N-phenyl-dioxo-hydro pyrimidines useful as hepatitis c virus (hcv) inhibitor
03/25/2014CA2665458C Preparation of azoxystrobin
03/25/2014CA2585983C Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases
03/20/2014WO2014040555A1 Nitrogen-containing heteroaromatic ring derivative as tyrosine kinase inhibitor
03/20/2014WO2014015935A3 Fluorenes and electronic devices containing them
03/20/2014WO2014009968A3 Process for rilpivirine using novel intermediate
03/20/2014US20140081023 PROCESS FOR THE PREPARATION OF 2-AMINO-5,8-DIMETHOXY[1,2,4]TRIAZOLO[1,5-c]PYRIMIDINE FROM 4-CHLORO-2,5-DIMETHOXYPYRIMIDINE
03/20/2014US20140080848 Aryl amine substituted pyrimidine and quinazoline and their use as anticaner drugs
03/20/2014US20140080835 Quinazolinone derivatives as parp inhibitors
03/20/2014US20140080832 IRE-1alpha INHIBITORS
03/20/2014US20140080803 Novel trpv3 modulators
03/20/2014US20140080798 Vegfr3 inhibitors
03/20/2014US20140080780 identification of compounds that disperse tdp-43 inclusions
03/20/2014US20140079736 Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
03/20/2014US20140079666 Pyrimidinone compounds and methods for preventing and treating influenza
03/19/2014EP2708532A1 4-aminoquinazoline derivatives and uses thereof
03/19/2014EP2708531A1 Crystalline Forms Of 3-[5-Chloro-4-[(2,4-difluorobenzyl) oxy]-6-oxopyrimidin-1(6H)-yl]-N-(2-hydroxyethyl)-4-methylbenzamide
1 ... 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 ... 427